ArticleJournal of medical case reports2025
Multidermatomal herpes zoster in an immunocompetent, fully vaccinated 17-year-old female: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHerpes zoster, commonly known as shingles, results from the reactivation of varicella zoster virus, typically occurring in older adults. The advent of varicella vaccination has caused a decline in primary varicella infection cases; however, herpes zoster still occurs, albeit rarely, in fully vaccinated children. CASE PRESENTATION: This report presents a case of herpes zoster in a fully vaccinated 17-year-old white American female, highlighting the importance of considering herpes zoster in immunocompetent, vaccinated children. The patient presented with a rash along multiple dermatomes, which spread despite antiviral treatment. After completion of the antiviral treatment, the rash eventually receded, and she was left with no residual symptoms.
conclusionThis case underscores the need for clinicians to recognize and manage uncommon diseases such as herpes zoster in the pediatric population, regardless of vaccination status, to prevent adverse outcomes. Although this patient did not have any residual symptoms, mortality, or morbidity, there could be a high probability for complications if there becomes optical or meningeal involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.